Tetragon Partners Gp Ltd Portfolio Stock Holdings
According to the SEC 13F filed on August 13, 2026, Tetragon Partners Gp Ltd disclosed 30 stock positions valued at approximately $614.32M as of quarter-end June 30, 2026. The largest holdings include UIPATH INC, KOLIBRI GLOBAL ENERGY INC, and AUTOLUS THERAPEUTICS LTD.
- Report Period
- June 30, 2026
- No. of Stocks
- 30
- Portfolio Value
- $614.32M
Holdings by Sector
Tetragon Partners Gp Ltd Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| UIPATH INC | PATH | Technology | 54.76% | 30,950,000 | +5,742,372 | +22.78% | $336,426,500 |
| KOLIBRI GLOBAL ENERGY INC | KGEI | Energy | 5.51% | 6,834,504 | - | - | $33,845,142 |
| AUTOLUS THERAPEUTICS LTD | AUTL | Healthcare | 2.47% | 9,500,000 | - | - | $15,200,000 |
| LYFT INC | LYFT | Technology | 2.38% | 1,000,000 | - | - | $14,610,000 |
| DEFINIUM THERAPEUTICS INC | DFTX | Other | 2.20% | 286,990 | +86,996 | +43.50% | $13,500,010 |
| WORKIVA INC | WK | Technology | 1.97% | 250,000 | - | - | $12,127,500 |
| SPRINKLR INC | CXM | Technology | 1.85% | 2,200,000 | - | - | $11,352,000 |
| MBX BIOSCIENCES INC | MBX | Other | 1.83% | 203,543 | +58,063 | +39.91% | $11,235,574 |
| ALKAMI TECHNOLOGY INC | ALKT | Technology | 1.77% | 600,284 | +600,284 | +100.00% | $10,877,146 |
| CELLDEX THERAPEUTICS INC NEW | CLDX | Healthcare | 1.76% | 290,441 | -21,875 | -7.00% | $10,807,310 |
| RELAY THERAPEUTICS INC | RLAY | Healthcare | 1.74% | 570,311 | +388,768 | +214.15% | $10,670,519 |
| ARROWHEAD PHARMACEUTICALS IN | ARWR | Healthcare | 1.73% | 130,484 | +3,286 | +2.58% | $10,635,751 |
| PHARVARIS N V | PHVS | Other | 1.66% | 295,627 | +74,016 | +33.40% | $10,222,782 |
| ALKERMES PLC | ALKS | Healthcare | 1.62% | 189,979 | +30,188 | +18.89% | $9,953,950 |
| IMMUNOVANT INC | IMVT | Healthcare | 1.61% | 255,934 | +37,427 | +17.13% | $9,861,137 |
| SILENCE THERAPEUTICS PLC | SLN | Healthcare | 1.37% | 764,256 | +134,095 | +21.28% | $8,391,531 |
| DYNE THERAPEUTICS INC | DYN | Healthcare | 1.29% | 356,657 | +98,525 | +38.17% | $7,921,352 |
| IONIS PHARMACEUTICALS INC | IONS | Healthcare | 1.25% | 97,173 | +55,409 | +132.67% | $7,704,847 |
| AGIOS PHARMACEUTICALS INC | AGIO | Healthcare | 1.24% | 205,579 | +40,740 | +24.72% | $7,629,037 |
| HARMONY BIOSCIENCES HLDGS IN | HRMY | Healthcare | 1.19% | 201,036 | +81,696 | +68.46% | $7,319,721 |
| KRYSTAL BIOTECH INC | KRYS | Healthcare | 1.19% | 19,668 | - | - | $7,310,006 |
| ANNEXON INC | ANNX | Healthcare | 1.15% | 1,242,455 | -50,000 | -3.87% | $7,094,418 |
| CELCUITY INC | CELC | Healthcare | 1.09% | 64,110 | +64,110 | +100.00% | $6,707,188 |
| WARNER BROS DISCOVERY INC | WBD | Communication Services | 1.08% | 250,000 | -673,725 | -72.94% | $6,665,000 |
| AMYLYX PHARMACEUTICALS INC | AMLX | Healthcare | 0.87% | 297,926 | -19,951 | -6.28% | $5,350,751 |
| ACADIA PHARMACEUTICALS INC | ACAD | Healthcare | 0.69% | 167,875 | +23,255 | +16.08% | $4,247,238 |
| SNOWFLAKE INC | SNOW | Technology | 0.41% | 10,000 | - | - | $2,545,000 |
| ACLARIS THERAPEUTICS INC | ACRS | Healthcare | 0.34% | 400,000 | +400,000 | +100.00% | $2,116,000 |
| TECTONIC THERAPEUTIC INC | TECX | Healthcare | 0.26% | 46,516 | +8,928 | +23.75% | $1,598,988 |
| MONTE ROSA THERAPEUTICS INC | GLUE | Healthcare | 0.22% | 56,052 | +56,052 | +100.00% | $1,356,458 |
Showing 30 of 30 holdings in the latest reporting period.
Tetragon Partners Gp Ltd Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | AXSM | Axsome Therapeutics, Inc. | CALL | 35,000 | $8,566,950 |
| Q2 2026 | RARE | Ultragenyx Pharmaceutical Inc. | CALL | 100,000 | $3,339,000 |
| Q2 2026 | SLN | Silence Therapeutics Plc - Amer | CALL | 300,000 | $3,294,000 |
| Q2 2026 | AGIO | Agios Pharmaceuticals, Inc. | CALL | 50,000 | $1,855,500 |
| Q2 2026 | TENX | Tenax Therapeutics, Inc. | CALL | 75,100 | $1,092,705 |
| Q2 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | CALL | 8,500 | $152,660 |
Showing 6 of 6 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.